The following is a summary of “Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study,” published in the February ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

Fact checked by Nick Blackmer It all started back in the spring of 2018 with a painful bump in my armpit. Confused, scared, ...

Managing hidradenitis suppurativa (HS) poses an array of challenges ... Her professional interests include Mohs micrographic surgery, cosmetic and laser procedures, and immunodermatology.

Hidradenitis suppurativa is managed with biologics like ... 1 Prior to its approval, patients with HS relied on surgery to remove the skin affected by the disease along with antibiotics.

Discover a review in which diabetes was investigated in 5 studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.

A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...

Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...

When it comes to managing hidradenitis suppurativa (HS) in special patient populations, new guidelines rate the existing evidence as “strong” for the following clinical scenarios: The ...

The following is a summary of “Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis,” published in the January 2025 issue of Dermatology by Trupiano et al. Itch ...

NICE is unable to make a recommendation about the use in the NHS of bimekizumab (Bimzelx) for treating moderate to severe hidradenitis suppurativa in adults. This is because UCB Pharma withdrew from ...